ReportWire

First LSD-Based Drug Receives FDA Breakthrough Designation, Paving the Way for New Innovation

[ad_1]

The FDA has given MindMed’s LSD-based drug breakthrough-therapy status, paving the way for more innovation and investment in the space.

[ad_2]

Chloe Aiello

Source link